{"id":3243,"date":"2018-06-12T19:05:38","date_gmt":"2018-06-12T17:05:38","guid":{"rendered":"https:\/\/www.aieop.org\/web\/web\/?page_id=3243"},"modified":"2025-11-17T09:10:27","modified_gmt":"2025-11-17T08:10:27","slug":"linee-guida-consensum","status":"publish","type":"page","link":"https:\/\/www.aieop.org\/web\/operatori-sanitari\/linee-guida-consensum\/","title":{"rendered":"Linee Guida\/Consensus"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:20px;--awb-padding-bottom:20px;--awb-background-color:#ffffff;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-two pagina-interna\" style=\"--awb-sep-color:#c4c4c4;\"><h2 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;\">Linee Guida\/Consensus<\/h2><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container\"><div class=\"title-sep sep-double sep-solid\" style=\"border-color:#c4c4c4;\"><\/div><\/div><\/div><div class=\"fusion-text fusion-text-1\"><div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In questa sezione proponiamo la documentazione AIEOP disponibile per tutti, su argomenti specifici.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"accordian fusion-accordian toggle-custom-01 link-custom-01\" style=\"--awb-border-size:1px;--awb-icon-size:1px;--awb-content-font-size:13px;--awb-icon-alignment:left;--awb-hover-color:#f9f9f9;--awb-border-color:#cccccc;--awb-background-color:#ffffff;--awb-divider-color:#e0dede;--awb-divider-hover-color:#e0dede;--awb-icon-color:#ffffff;--awb-title-color:#333333;--awb-content-color:#747474;--awb-icon-box-color:#333333;--awb-toggle-hover-accent-color:#ffffff;--awb-title-font-family:&quot;Montserrat&quot;;--awb-title-font-weight:400;--awb-title-font-style:normal;--awb-title-font-size:13px;--awb-content-font-family:&quot;Montserrat&quot;;--awb-content-font-style:normal;--awb-content-font-weight:400;\"><div class=\"panel-group fusion-toggle-icon-unboxed\" id=\"accordion-3243-1\"><div class=\"fusion-panel panel-default panel-d161863d9ab163976 fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_d161863d9ab163976\"><a aria-expanded=\"false\" aria-controls=\"d161863d9ab163976\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#d161863d9ab163976\" href=\"#d161863d9ab163976\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Documenti realizzati in ambito AIEOP<\/span><\/a><\/h4><\/div><div id=\"d161863d9ab163976\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_d161863d9ab163976\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/04\/Allegato-6-Linee-guida-per-la-proposta-e-gestione-degli-studi-AIEOP.pdf\" target=\"_blank\" rel=\"noopener\">Allegato 6 &#8211; Linee guida per la proposta e gestione degli studi AIEOP (aprile 2023)<\/a><\/p>\n<div>1. LINEE GUIDA PER LA RICHIESTA E L\u2019UTILIZZO DEI DATI DELLO STUDIO AIEOP Mod.1.01 (<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2025\/11\/policy-aieop-per-Mod-1.01.pdf\" target=\"_blank\" rel=\"noopener\">policy aieop per Mod 1.01)<\/a><\/div>\n<div>2. Allegato 1 Modulo richiesta dati studio AIEOP Mod.1.01 (\u00a0<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2025\/11\/Allegato-1_RichiestaDati.pdf\" target=\"_blank\" rel=\"noopener\">Allegato 1_RichiestaDati.pdf\u00a0 <\/a><a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2025\/11\/Allegato-1_RichiestaDati.docx\" target=\"_blank\" rel=\"noopener\">Allegato 1_RichiestaDati.word)<\/a><\/div>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-db52df06d29855c0a fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_db52df06d29855c0a\"><a aria-expanded=\"false\" aria-controls=\"db52df06d29855c0a\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#db52df06d29855c0a\" href=\"#db52df06d29855c0a\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Linee Guida dell'OMS<\/span><\/a><\/h4><\/div><div id=\"db52df06d29855c0a\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_db52df06d29855c0a\"><div class=\"panel-body toggle-content fusion-clearfix\">&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/introduzione-LG-pediatriche-RM.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Introduzione alle Linee Guida OMS<\/a> a cura di C.I. Ripamonti e M. Massimino (Ed. Marzo 2014)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/WHO-Linee-Guida-Dolore-Persistente-pediatrico-2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee guida dell&#8217;OMS sul trattamento farmacologico del dolore persistente nei bambini con patologie croniche gravi<\/a> (Ed. 2014)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/Brochure-WHO-farmacisti-2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Dolore persistente nei bambini: opuscolo per farmacisti estratto dalle Linee guida OMS<\/a> (Ed. 2014)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/Brochure-WHO-medici-infermieri-2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Dolore persistente nei bambini: opuscolo per medici e personale infermieristico estratto dalle Linee guida OMS<\/a> (Ed. 2014)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/Brochure-WHO-politiche-sanitarie-2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Dolore persistente nei bambini: opuscolo per i Responsabili delle politiche estratto dalle Linee guida OMS<\/a> (Ed. 2014)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/WHO-pieghevole_posologia-2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Posologia anelgesici per bambini<\/a> (Ed. 2014)<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-58e4a53161c52458d fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_58e4a53161c52458d\"><a aria-expanded=\"false\" aria-controls=\"58e4a53161c52458d\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#58e4a53161c52458d\" href=\"#58e4a53161c52458d\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Siop Europe<\/span><\/a><\/h4><\/div><div id=\"58e4a53161c52458d\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_58e4a53161c52458d\"><div class=\"panel-body toggle-content fusion-clearfix\">&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/European_Standards_of_Care_for_Children_with_Cancer_1_03_2010_ENG.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">European Standards of care for children with cancer<\/a> (14 ottobre 2009)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/European-Standards-of-Care-for-Children-with-Cancer_1-03-2010_IT.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Standard Europei per la cura dei bambini affetti da tumore<\/a> (14 ottobre 2009)<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-96371d343e56093a5 fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_96371d343e56093a5\"><a aria-expanded=\"false\" aria-controls=\"96371d343e56093a5\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#96371d343e56093a5\" href=\"#96371d343e56093a5\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Chirurgia<\/span><\/a><\/h4><\/div><div id=\"96371d343e56093a5\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_96371d343e56093a5\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211; <a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2024\/03\/Surgical-Practice-Guidelines.pdf\" target=\"_blank\" rel=\"noopener\">Surgical Practice Guidelines<\/a> (2022)<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-b548a56b70505b879 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_b548a56b70505b879\"><a aria-expanded=\"false\" aria-controls=\"b548a56b70505b879\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#b548a56b70505b879\" href=\"#b548a56b70505b879\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Terapia di Supporto<\/span><\/a><\/h4><\/div><div id=\"b548a56b70505b879\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_b548a56b70505b879\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/LG-CVC-trombosi-AIEOP-2014doc.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee Guida sull&#8217;uso del Catetere venoso centrale in oncoematologia pediatric<\/a>a (a cura del GDL Terapia di supporto in collaborazione con i GDL infezioni, chirurgia pediatrica, coagulazione ed infermieristico) 2014<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/guidelines-on-CVC-2013.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders<\/a>. Ann Hematol (2013) 92:1405\u20131412<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/guidelines-on-vaccinations-in-paediatric-haematology-and-oncology-patients-vol-2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients<\/a> (Hindawi Publishing Corporation, BioMed Research International, Volume 2014)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/vaccinazione-nei-bambini-chemioterapici-01.2011-rev.1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee Guida per le vaccinazioni nei bambini oncoematologici sottoposti a chemioterapia<\/a> (Medico e Bambino &#8211; 8\/2010)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2019\/06\/Consensus-10-aprile-Versione-finale-rivista-approvata.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Consensus on Pediatric Pain in the Emergency Room<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2022\/01\/Cellini-et-al-JVA-2020-Linee-guida-CVC-AIEOP-2020.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee guida AIEOP Gestione CVC<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2022\/01\/Giordano-et-al-Ann-Hematol-2015-CVC.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee Guida AIEOP Gestione complicanze occlusive e trombotiche CVC<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2022\/01\/Crocoli-et-al-JVA-2015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee Guida AIEOP CVC (tipo CVC, tecnica posizionamento)<\/a><br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/02\/Linee-Guida-Zoonosi-GdL-Infezioni-2023.pdf\" target=\"_blank\" rel=\"noopener\">&#8211; Linee Guida Zoonosi GdL Infezioni 2023<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/06\/Raccomandazioni-sulla-gestione-dei-disturbi-dellomeostasi-glicemica-secondari-a-malattia-ematologica-oncologica-e-a-trapianto-dorgano-in-eta-pediatrica.pdf\" target=\"_blank\" rel=\"noopener\">Raccomandazioni sulla gestione dei disturbi dell\u2019omeostasi glicemica secondari a malattia ematologica, oncologica e a trapianto d\u2019organo in et\u00e0 pediatrica<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-3bea69865271099d4 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_3bea69865271099d4\"><a aria-expanded=\"false\" aria-controls=\"3bea69865271099d4\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#3bea69865271099d4\" href=\"#3bea69865271099d4\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Infezioni<\/span><\/a><\/h4><\/div><div id=\"3bea69865271099d4\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_3bea69865271099d4\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/sepsibatt.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Definizioni delle sepsi<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/lgvaricella.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Consensus sul vaccino per la varicella<\/a><br \/>\n&#8211;\u00a0<a href=\"\/web\/wp-content\/uploads\/2020\/11\/CONSENSUS-IRR-2020-4-3.pdf\">CONSENSUS IRR 2020 (4) (3)<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2022\/01\/Consensus-Vaccinazioni-pazienti-emofilici.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Consensus Vaccinazioni pazienti emofilici<\/a><br \/>\n<a href=\"\/web\/wp-content\/uploads\/2022\/01\/Consensus-v13-GdL-Infezioni-Vaccinazione-COVID-19.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">&#8211; <\/a><a href=\"\/web\/wp-content\/uploads\/2022\/01\/GdL-Infezioni-Consensus-Vaccinazione-COVID-19-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">GdL Infezioni, Consensus Vaccinazione COVID-19<\/a>; 04.01.2022<br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2022\/02\/PROSPETTIVE-IN-PEDIATRIA-Ottobre-Dicembre-2021-COVID19-in-Oncoematologia-pediatrica-1.pdf\" target=\"_blank\" rel=\"noopener\">&#8211; PROSPETTIVE-IN-PEDIATRIA-Ottobre-Dicembre-2021-COVID19-in-Oncoematologia-pediatrica<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2022\/02\/Consensus-on-COVID\u201019-Vaccination-in-Pediatric-Oncohematological-Patients-on-Behalf-of-Infectious-Working-Group-of-Italian-Association-of-Pediatric-Hematology-Oncology.pdf\" target=\"_blank\" rel=\"noopener\">Consensus on COVID\u201019 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-629a68a5db332a61e fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_629a68a5db332a61e\"><a aria-expanded=\"false\" aria-controls=\"629a68a5db332a61e\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#629a68a5db332a61e\" href=\"#629a68a5db332a61e\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Trapianto di cellule staminali emopoietiche<\/span><\/a><\/h4><\/div><div id=\"629a68a5db332a61e\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_629a68a5db332a61e\"><div class=\"panel-body toggle-content fusion-clearfix\">&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/racc.-mucopolisaccaridi-TMO-25.10.2010.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Raccomandazioni per la diagnosi e cura della mucopolisaccaridosi di tipo I<\/a> (25 Ottobre 2010)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/Il_TCSE_nell_Anemia_Falciforme_07.07.2010.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Il trapianto di cellule staminali emopoietiche nell&#8217;anemia falciforme<\/a> (07 Luglio 2010)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/17.06.2010_Documento_Cordone_Autologo.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Le cellule staminali da cordone ombelicale<\/a> (17 giugno 2010)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/sangue_cordonale_21.04.2010.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Donazione di sangue cordonale<\/a> (21 aprile 2010)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/opuscolo_su_pazienti_off_therapy_dopo_trapianto.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Assistenza sul territorio del paziente sottoposto in et\u00e0 pediatrica a trapianto di cellule staminali emopoietiche<\/a> (Edizione Febbraio 2010)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/lgtcse.zip\" target=\"_blank\" rel=\"noopener noreferrer\">Raccomandazioni per la gestione dei pazienti pediatrici sottoposti a trapianto di cellule staminali emopoietiche<\/a> (Edizione Aprile 2003)<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-ea50b4aac16db620e fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_ea50b4aac16db620e\"><a aria-expanded=\"false\" aria-controls=\"ea50b4aac16db620e\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#ea50b4aac16db620e\" href=\"#ea50b4aac16db620e\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Difetti della Coagulazione<\/span><\/a><\/h4><\/div><div id=\"ea50b4aac16db620e\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_ea50b4aac16db620e\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/raccomandazioni-per-la-gestione-trombocitosi-v.-1.2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Raccomandazioni per la gestione delle trombocitosi in et\u00e0 pediatrica<\/a> (v. 1.2; febbraio 2015)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2017\/05\/ptilg.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee Guida sulle PTI Acute<\/a> (Haematologica 2000; 85: 420-424)<br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2018\/03\/LG-ITP-cronica-18.10.17-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">LG ITP cronica 18.10.2017<\/a><br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2022\/09\/Newly-diagnosed-and-persitent-ITP-5.8.22.pdf\" target=\"_blank\" rel=\"noopener\">&#8211; Newly diagnosed and persitent ITP 5.8.22<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-8a4143a96f0417163 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_8a4143a96f0417163\"><a aria-expanded=\"false\" aria-controls=\"8a4143a96f0417163\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#8a4143a96f0417163\" href=\"#8a4143a96f0417163\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Insufficienza midollare<\/span><\/a><\/h4><\/div><div id=\"8a4143a96f0417163\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_8a4143a96f0417163\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211; <a href=\"\/web\/wp-content\/uploads\/2018\/04\/Linee-guida-per-linquadramento-diagnostico-e-glossario-delle-neutropenie-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee guida per l&#8217;inquadramento diagnostico e glossario delle neutropenie<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2021\/08\/Raccomandazioni-AA-2021.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Raccomandazioni Diagnostico Terapeutiche sulle Aplasie Midollari Acquisite in et\u00e0 pediatrica<\/a><br \/>\n&#8211; <a href=\"\/web\/wp-content\/uploads\/2018\/04\/Raccomandazioni-per-trattamento-e-FUP-delle-neutropenie-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Raccomandazioni per trattamento e FUP delle neutropenie<\/a><br \/>\n<a href=\"\/web\/wp-content\/uploads\/2018\/04\/Diagnostica-molecolare-nelle-Insufficienze-midollare-e-diagnosi-neutropenia-autoimmmune-elenco-laboratori-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">&#8211; Diagnostica molecolare nelle Insufficienze midollare e diagnosi neutropenia autoimmmune &#8211; elenco laboratori<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-d0a5bb4192a928b1b fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_d0a5bb4192a928b1b\"><a aria-expanded=\"false\" aria-controls=\"d0a5bb4192a928b1b\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#d0a5bb4192a928b1b\" href=\"#d0a5bb4192a928b1b\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Neuroblastoma<\/span><\/a><\/h4><\/div><div id=\"d0a5bb4192a928b1b\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_d0a5bb4192a928b1b\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211;<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2024\/05\/Recidive-Neuroblastoma-ver-17.3.24.pdf\" target=\"_blank\" rel=\"noopener\"> Recidive Neuroblastoma ver 17.3.24<\/a><\/p>\n<p>&#8211; <a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2025\/06\/Neuroblastoma_Guida.pdf\">Neuroblastoma_Guida<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-48a849fc8cdcf9556 fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_48a849fc8cdcf9556\"><a aria-expanded=\"false\" aria-controls=\"48a849fc8cdcf9556\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#48a849fc8cdcf9556\" href=\"#48a849fc8cdcf9556\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Patologie del Globulo Rosso<\/span><\/a><\/h4><\/div><div id=\"48a849fc8cdcf9556\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_48a849fc8cdcf9556\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211; <a href=\"\/web\/wp-content\/uploads\/2018\/03\/Linee-guida-Aieop-SCD-2018.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Linee guida per la gestione della malattia drepanocitica pediatrica in Italia<\/a> (Versione 3 del 30.01.2018)<\/p>\n<p>&#8211;<a href=\"\/web\/wp-content\/uploads\/2018\/03\/AEA-6-nov13.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Raccomandazioni per la gestione del bambino con Anemia Emolitica Autoimmune<\/a> (Versione 1 del 01\/11\/2013)<\/p>\n<p>&#8211;<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/05\/Linee-guida-per-la-gestione-della-malattia-drepanocitica-pediatrica-in-Italia.pdf\">Linee guida per la gestione della malattia drepanocitica pediatrica in Italia<\/a> <a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/04\/LG-AIEOP-SCD_Revisione-4_Aprile-2023.pdf\" target=\"_blank\" rel=\"noopener\">(<\/a>Versione 4, aprile 2023)<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-ec9bf434184110689 fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_ec9bf434184110689\"><a aria-expanded=\"false\" aria-controls=\"ec9bf434184110689\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#ec9bf434184110689\" href=\"#ec9bf434184110689\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Sarcomi Ossei<\/span><\/a><\/h4><\/div><div id=\"ec9bf434184110689\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_ec9bf434184110689\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>&#8211;<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/07\/Assessment-of-resection-margins-in-bone-sarcoma-guidelines.pdf\" target=\"_blank\" rel=\"noopener\">Assessment of resection margins in bone sarcoma guidelines<\/a><br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/07\/Bone-sarcomas-ESMO-EURACAN-GENTURIS-ERN-PaedCan-guidelines.pdf\" target=\"_blank\" rel=\"noopener\">-Bone sarcomas ESMO-EURACAN-GENTURIS-ERN PaedCan guidelines<\/a><br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/07\/ESTRO-ACROP-guidelines-for-external-beam-radiotherapy-of-patients-with-complicated-bone-metastases.pdf\">-ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases<\/a><br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/07\/ESTRO-ACROP-guidelines-uncomplicated-bone-metastases-radiotherapy.pdf\">-ESTRO ACROP guidelines uncomplicated bone metastases radiotherapy<\/a><br \/>\n<a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2023\/07\/ESTRO-ACROP-guidelines-uncomplicated-bone-metastases-radiotherapy.pdf\">&#8211;<\/a><a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2024\/01\/ACC_SOP_Biological-Material.pdf\" target=\"_blank\" rel=\"noopener\">ACC_SOP_Biological Material<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-ed498e5be3288ef54 fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_ed498e5be3288ef54\"><a aria-expanded=\"false\" aria-controls=\"ed498e5be3288ef54\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#ed498e5be3288ef54\" href=\"#ed498e5be3288ef54\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Tumori Cerebrali<\/span><\/a><\/h4><\/div><div id=\"ed498e5be3288ef54\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_ed498e5be3288ef54\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-10038\" src=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2024\/02\/raccomandazioni-per-il-medullo-a-rischio-standard.png\" alt=\"\" width=\"640\" height=\"360\" \/><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-0dfa90e63ff5e7dbe fusion-toggle-has-divider\" style=\"--awb-title-color:#333333;\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_0dfa90e63ff5e7dbe\"><a aria-expanded=\"false\" aria-controls=\"0dfa90e63ff5e7dbe\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-3243-1\" data-target=\"#0dfa90e63ff5e7dbe\" href=\"#0dfa90e63ff5e7dbe\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Sindromi Mielodisplastiche<\/span><\/a><\/h4><\/div><div id=\"0dfa90e63ff5e7dbe\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_0dfa90e63ff5e7dbe\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2024\/02\/2017_08_16_ConsensusGuidelinesHSCTinMDSandJMML_v1.34.pdf\" target=\"_blank\" rel=\"noopener\">2017_08_16_ConsensusGuidelinesHSCTinMDSandJMML_v1.34<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":1100,"parent":294,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3243","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/pages\/3243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/comments?post=3243"}],"version-history":[{"count":38,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/pages\/3243\/revisions"}],"predecessor-version":[{"id":11571,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/pages\/3243\/revisions\/11571"}],"up":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/pages\/294"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/media\/1100"}],"wp:attachment":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/media?parent=3243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}